Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury.

Vincent F Simmon ; (2009) Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury. Trials, 10 (1). 110-. ISSN 1745-6215 DOI: 10.1186/1745-6215-10-110

Copy

A response to and comment on The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury, by Haleema Shakur, Ian Roberts, et al.

Item Type	Article
ISI	273070400002
Date Deposited	17 Oct 2011 14:50

html

html: 111
subject: Published Version
: Available under Creative Commons: Attribution 3.0

Download

Atom

BibTeX

OpenURL ContextObject in Span

Multiline CSV

OpenURL ContextObject

Dublin Core

MPEG-21 DIDL

Data Cite XML

EndNote

HTML Citation

JSON

MARC (ASCII)

MARC (ISO 2709)

METS

MODS

RDF+N3

RDF+N-Triples

RDF+XML

RIOXX2 XML

Reference Manager

Refer

Simple Metadata

ASCII Citation

EP3 XML

Export

Downloads